3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
2
Neuroblastoma
2
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Ganglioneuroblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Adenoma, Islet Cell
1
Adenocarcinoma
1
Interventions
pembrolizumab
9
Nivolumab
5
aldesleukin
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Interleukin-2
2
Cyclophosphamide
2
Biopsy
2
sargramostim
1
relatlimab
1
regorafenib
1
prednylidene
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
avelumab
1
aflibercept
1
X-Rays
1
Sirolimus
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Prednisone
1
Predictive Learning Models
1
Paclitaxel
1
Opdualag
1
NEO212
1
Lidocaine, Prilocaine Drug Combination
1
Laparoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Merkel Cell
×
Colony-Stimulating Factors
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled